Study S000811

Effect of GLP-1 Agonist Therapy on Insulin Secretion in Adults With Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a Randomized, Open-label, Cross-over Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04731272
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2021-07-16
Primary completion: 2027-06-30
Lead sponsor: University of Pennsylvania
Conditions: Cystic Fibrosis; Pancreatic Insufficiency; Abnormal Glucose Tolerance; Diabetes
Interventions: DRUG:Dulaglutide 0.75Mg/0.5Ml Inj Pen
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Early-phase insulin secretion [18 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.